XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Balance at Dec. 31, 2021 $ 41,522 $ 216 $ 97,778 $ (56,472)  
Balance (in shares) at Dec. 31, 2021   21,614,000      
Issuance of unrestricted stock (in shares)   28,000      
Stock-based compensation expense 430   430    
Net loss (1,278)     (1,278)  
Balance at Mar. 31, 2022 40,674 $ 216 98,208 (57,750)  
Balance (in shares) at Mar. 31, 2022   21,642,000      
Balance at Dec. 31, 2021 41,522 $ 216 97,778 (56,472)  
Balance (in shares) at Dec. 31, 2021   21,614,000      
Net loss (2,567)        
Balance at Jun. 30, 2022 39,853 $ 217 98,675 (59,039)  
Balance (in shares) at Jun. 30, 2022   21,681,000      
Balance at Mar. 31, 2022 40,674 $ 216 98,208 (57,750)  
Balance (in shares) at Mar. 31, 2022   21,642,000      
Issuance of common stock under employee stock purchase plan (in shares)   40,000      
Issuance of common stock under employee stock purchase plan 93 $ 1 92    
Repurchase of common stock (3)   (3)    
Repurchase of common stock (in shares)   (1,000)      
Stock-based compensation expense 378   378    
Net loss (1,289)     (1,289)  
Balance at Jun. 30, 2022 39,853 $ 217 98,675 (59,039)  
Balance (in shares) at Jun. 30, 2022   21,681,000      
Balance at Dec. 31, 2022 $ 40,209 $ 211 98,306 (58,198) $ (110)
Balance (in shares) at Dec. 31, 2022 21,093,447 21,093,000      
Issuance of unrestricted stock   $ 1 (1)    
Issuance of unrestricted stock (in shares)   62,000      
Shares surrendered by employees to pay taxes related to unrestricted stock $ (15)   (15)    
Shares surrendered by employees to pay taxes related to unrestricted stock (in shares)   (9,000)      
Repurchase of common stock (341) $ (2) (339)    
Repurchase of common stock (in shares)   (191,000)      
Stock-based compensation expense 335   335    
Other comprehensive income (loss) 147       147
Net loss (1,568)     (1,568)  
Balance at Mar. 31, 2023 38,767 $ 210 98,286 (59,766) 37
Balance (in shares) at Mar. 31, 2023   20,955,000      
Balance at Dec. 31, 2022 $ 40,209 $ 211 98,306 (58,198) (110)
Balance (in shares) at Dec. 31, 2022 21,093,447 21,093,000      
Net loss $ (4,220)        
Balance at Jun. 30, 2023 $ 36,442 $ 211 98,740 (62,418) (91)
Balance (in shares) at Jun. 30, 2023 20,993,235 20,993,000      
Balance at Mar. 31, 2023 $ 38,767 $ 210 98,286 (59,766) 37
Balance (in shares) at Mar. 31, 2023   20,955,000      
Issuance of common stock under employee stock purchase plan (in shares)   38,000      
Issuance of common stock under employee stock purchase plan 52 $ 1 51    
Stock-based compensation expense 403   403    
Other comprehensive income (loss) (128)   0   (128)
Net loss (2,652)     (2,652)  
Balance at Jun. 30, 2023 $ 36,442 $ 211 $ 98,740 $ (62,418) $ (91)
Balance (in shares) at Jun. 30, 2023 20,993,235 20,993,000